Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Edouard

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1982
Long term effects of dichloromethylene diphosphonate in Paget's disease of boneP D Delmas, M C Chapuy, E Vignon, et al.
Bone|January 1, 1987
Primary bone oxalosis: the roles of oxalate deposits and renal osteodystrophyC L Benhamou, D Pierre, N Geslin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 1, 1987
The assessment of bone formation and bone resorption in osteoporosis: a comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kineticsJ Reeve, M E Arlot, P M Chavassieux, et al.
La Nouvelle Presse Medicale|November 29, 1980
[Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)]C Alexandre, M C Chapuy, C Bressot, et al.
Calcified Tissue International|January 1, 1993
Temporal variations in iliac trabecular bone formation in vertebral osteoporosisM E Arlot, J N Bradbeer, C Edouard, et al.
European Journal of Clinical Investigation|October 1, 1987
Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosisJ Reeve, M Arlot, T R Price, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1995
Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosisM Tellez, M E Arlot, E B Mawer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 1, 1991
hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responsesJ Reeve, J N Bradbeer, M Arlot, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|November 30, 1991
[Bone involvement in primary oxalosis. Study of 20 cases]C L Benhamou, T Bardin, D Tourlière, et al.
British Medical Journal|June 7, 1980
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trialJ Reeve, P J Meunier, J A Parsons, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1982
Long term effects of dichloromethylene diphosphonate in Paget's disease of boneP D Delmas, M C Chapuy, E Vignon, et al.
Bone|January 1, 1987
Primary bone oxalosis: the roles of oxalate deposits and renal osteodystrophyC L Benhamou, D Pierre, N Geslin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 1, 1987
The assessment of bone formation and bone resorption in osteoporosis: a comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kineticsJ Reeve, M E Arlot, P M Chavassieux, et al.
La Nouvelle Presse Medicale|November 29, 1980
[Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)]C Alexandre, M C Chapuy, C Bressot, et al.
Calcified Tissue International|January 1, 1993
Temporal variations in iliac trabecular bone formation in vertebral osteoporosisM E Arlot, J N Bradbeer, C Edouard, et al.
European Journal of Clinical Investigation|October 1, 1987
Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosisJ Reeve, M Arlot, T R Price, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1995
Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosisM Tellez, M E Arlot, E B Mawer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 1, 1991
hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responsesJ Reeve, J N Bradbeer, M Arlot, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|November 30, 1991
[Bone involvement in primary oxalosis. Study of 20 cases]C L Benhamou, T Bardin, D Tourlière, et al.
British Medical Journal|June 7, 1980
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trialJ Reeve, P J Meunier, J A Parsons, et al.
Pageof 6